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Reported prevalences of human herpesvirus 8 (HHV-8) (Kaposi’s sarcoma-associated herpesvirus) in semen
have ranged widely. This is possibly due to differences in assay sensitivity, geographic or population-based
differences in the true presence of the virus in semen, and PCR contamination. This study assessed interlaboratory sensitivity and reproducibility in the analysis of blinded experimental panels, each consisting of 48
specimens and being composed of semen specimens from different healthy artificial-insemination donors (n 5
30) and human immunodeficiency virus (HIV)-infected patients (n 5 7) plus positive (n 5 4) and negative (n 5
7) controls. The experimental panels analyzed in each laboratory were identical except for being independently
coded. Of 10 experiments done in five laboratories, 5 experiments from three laboratories had evidence of PCR
contamination; all instances of contamination were in the context of nested PCR procedures. In the experiments with no false-positive results, HHV-8 DNA was detected in three (8%) of the 37 semen specimens (two
from artificial-insemination donors and one from an HIV-positive patient) but in only 3 (1.6%) of the 184 PCRs
in which these specimens were analyzed. This suggests that HHV-8 DNA is present in semen at concentrations
that can be too low to allow its consistent detection. This study emphasizes the importance of performing
blinded, multi-institution experiments to provide a coherent basis for comparing results and to motivate
standardization of methods.
and reproducibility of PCR detection of HHV-8 DNA in semen among five laboratories.

Human herpesvirus 8 (HHV-8) (or Kaposi’s sarcoma [KS]associated herpesvirus) is detected in essentially all KS lesions
(6), in which it is present in the spindle cells that are a major
pathologic hallmark of the disease (4, 13, 23). An etiologic
association between the virus and the disease is suggested by
the temporal association between the onset of KS and the
development of both detectable HHV-8 DNA in the blood and
reactivity in HHV-8 serologic assays (9, 20). In addition,
HHV-8 encodes genes that can modulate cellular growth properties and possibly play a direct role in KS pathogenesis (22).
Because the epidemiology of AIDS-associated KS suggests
that the disease is caused by a sexually transmitted agent other
than human immunodeficiency virus (HIV) type 1 (2), semen
has been studied as a possible route of HHV-8 transmission. In
addition to the possibility of interrupting transmission if the
virus is transmitted via semen, it is important to ascertain
whether this potentially oncogenic virus is present in semen
donated for use in artificial insemination. The prevalences of
HHV-8 DNA in prostate and semen as measured by PCR have
ranged from zero to over 90% (1, 7, 8, 10–12, 15–19, 23, 24).
Possible explanations for this discrepancy include HIV status,
geographic or population-based differences in HHV-8 prevalence, laboratory-to-laboratory differences in assay sensitivity,
and PCR contamination. These possibilities are not mutually
exclusive. This study was designed to compare the sensitivity

MATERIALS AND METHODS
Experimental panels. Experimental panels each consisted of 48 specimens
allocated as follows: 7 semen specimens from different HIV-positive men who
have sex with men; 30 semen specimens obtained from different healthy artificialinsemination donors; 4 positive control BCBL-1 cell specimens containing approximately 1,000, 100, 10, and 1 HHV-8 genomic copies per 10 ml; 3 aliquots of
Molt-3 cells (a T-cell line that is presumed to be HHV-8 free and that was
propagated in a room not used for HHV-8 work by someone who did not work
with HHV-8); and 4 aliquots of sterile distilled water. Several experimental
panels that were identical in composition but independently coded were prepared.
Semen specimens were prepared as 3:1 dilutions of semen with a semen
stabilization buffer (100 mM NaCl, 5.365 mM KCl, 2.721 mM CaCl2 z 2H2O,
0.492 mM MgCl2, 12.85 mM sodium lactate, 0.321 mM NaH2PO4, 30.949 mM
NaHCO3, 20.0 mM HEPES, 50.0 mM sucrose, 133.2 mM glycine, 5.51 mM
glucose, 28% [vol/vol] glycerol, 1 to 2% human serum albumin) (obtained as a
gift from an artificial-insemination bank) that is used to stabilize semen for the
purpose of artificial insemination. Semen was divided into aliquots by volume,
not by cell density. Semen manipulations were done in a biological safety cabinet
located in a laboratory that had not been used for any HHV-8-related work and
were performed by a person who had not previously done HHV-8 laboratory
work. Experimental panels were shipped to collaborating laboratories on dry ice.
PCR methods. Each laboratory followed its standard procedures for HHV-8
PCR; thus, procedures varied from laboratory to laboratory.
(i) Laboratory A. Specimens were separated into cell pellets and supernatants
by centrifugation at 800 3 g for 5 min. One hundred microliters of lysis buffer (10
mM Tris-HCl [pH 8.5], 1% lauryl ether, 0.2 mg of proteinase K per ml) and 1/10
volume of 103 lysis buffer were added to the cell pellets and supernatants,
respectively. The mixtures were incubated at 55°C for 3 h, followed by 98°C for
10 min. Ten-microliter aliquots were used in first-round PCRs. Primer sets were
from both open reading frame (ORF) 25 (experiment A1) and ORF 26 (experiment A2) (6, 15, 20). Amplifications were performed in a total reaction volume
of 0.1 ml as described previously (15). The supernatant fractions were all negative for HHV-8 with both primer sets in unnested and nested PCRs. Several
precautions were taken to prevent false-positive results: (i) rooms for pre- and
post-PCR procedures were physically separated; (ii) reagents were prepared in
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TABLE 1. Detection of HHV-8 DNA in semen and controls
Result for positive controls with the
following no. of HHV-8 copies/10
ml of template (n 5 1 each):

No. of HHV-8 PCR-positive specimens among:
Expt

A1
A2
B1
B2
C1
C2
D1
D2
D3
E
a
b

Nested PCR
performed

Yes
Yes
No
Yes
No
No
Yes
Yes
Yes
Yes

Semen from:
a

Negative controls

HIV-positive MSM
(n 5 7)

Artificial-insemination
donors (n 5 30)

Molt-3 cells
(n 5 3)

Water
(n 5 4)

1,000

100

10

1

0
0
1
2
0
0
0
0
0
1b

1
0
5
13
0
0
4
1
3
1

1
0
0
1
0
0
0
0
0
0

0
0
0
2
0
0
2
0
2
0

1
1
1
1
1
1
1
1
1
1

1
1
1
1
1
1
1
1
1
1

1
1
2
2
1
1
1
2
2
2

2
2
2
1
2
2
1
2
1
2

MSM, men who have sex with men.
n 5 6 due to one insufficient specimen.

large batches and stored in small aliquots; (iii) equipment such as the microcentrifuge, water baths, pipettes, tube racks, and other small equipment was designated for PCR work only; (iv) gloves were changed frequently; and (v) aerosolbarrier pipette tips, PCR tubes, and autoclaved, diethylpyrocarbonate-treated
water were sterilized by UV irradiation prior to PCR. In addition, serial dilutions
of positive controls (BCBL-1 cell DNA) with known HHV-8 genome copy
numbers were included to monitor the sensitivity and semiquantitation of the
PCR products. Negative controls were interspersed after every five experimental
samples.
(ii) Laboratory B. Specimens were mixed with 600 ml of NET-SDS buffer (100
mM NaCl, 10 mM Tris [pH 8], 1 mM EDTA, 0.1% sodium dodecyl sulfate
[SDS]), followed by addition of 8 ml of 10-mg/ml proteinase K and then incubation at 50°C for 1.5 h. The specimens were then extracted twice with phenol
and once with chloroform, followed by two ethanol precipitations; DNA was
suspended in 50 ml of 10 mM Tris HCl–0.1 mM EDTA, pH 8.0. All samples (2-ml
aliquots) were first assayed by PCR for the actin gene to confirm the presence of
DNA, and 5 ml was assayed with the HHV-8 ORF 26 primer set (KS-1,2)
described by Chang et al. (6), using KS-2 plus an internal primer (59TGCAGC
AGCTGTTGGTGTACCACAT) in nested reactions. Amplification specificity
was confirmed by Southern blot hybridization with a digoxigenin-labeled, cloned
120-bp internal amplimer generated by using primers 59CTGCAGCAGCTGTT
GGTGTACCAC and 59CCGTGTTGTCTACGTCCA.
(iii) Laboratory C. Specimens were thawed at room temperature, and 50 ml of
each specimen was denatured in guanidinium lysis buffer, phenol-chloroform
extracted, precipitated with isopropanol, washed once with 75% ethanol, and
then resuspended in 50 ml of 10 mM Tris (pH 8.0); 10 ml of DNA was used for
each PCR. Two primer pairs, KS-1,2 and KS-A,B (experiments C1 and C3,
respectively), were used to detect HHV-8 DNA. KS-1,2 amplifies the ORF 26
region as described by Chang et al. (6), and KS-A,B amplifies a segment of ORF
25 (14). PCR and liquid hybridization amplimer detection conditions were as
previously described (8, 14). For semiquantitation, log10 dilutions (10 to 10,000
copies) of plasmid DNA containing KS-1,2 target DNA were simultaneously
amplified as part of each PCR run. The intensity of the specific specimen band
was visually compared to this standard curve. To ensure that negative PCR
results were not due to inhibition of PCR, each KS-1,2 PCR mixture was spiked
with 50 copies of an internal positive control DNA, KS-fly2. KS-fly2 DNA is
identical to the KS-1,2 target DNA sequence except that the hybridization probe
sequence is replaced by a 21-bp Drosophila melanogaster DNA sequence (59TG
TCCTACCAACTACAATCCG). All negative PCR results from this laboratory
had positive KS-fly2 controls. Negative controls were built in by matching every
three specimens with an aliquot of uninfected HSB-2 cells processed in parallel
from DNA extraction through autoradiography. In addition, each PCR run
included at least one control containing all PCR reagents without any added
DNA.
(iv) Laboratory D. Cells were pelleted by centrifugation at 2,000 3 g. DNA was
extracted from cell pellets by digestion with proteinase K (100 mg/ml) in the
presence of 0.2% SDS and 40 mM 1,4-dithiothreitol, followed by phenol-chloroform extraction and then ethanol precipitation. Samples were suspended in 50
ml of 10 mM Tris HCl–0.1 mM EDTA (pH 8.0) and then spectrophotometrically
quantified. About 500 ng of DNA was used in each PCR; when the amount of
DNA recovered was insufficient for quantification, 10 ml of the suspension was
used. Ten negative control samples, consisting of salmon sperm DNA in TrisEDTA buffer, that were processed in parallel were always negative. Twelve
nested-PCR-negative controls lacking DNA template were included in each PCR
experiment and were always negative. Both kinds of negative control specimens
were inserted between sets of five or six experimental specimens. Experiments

D1 and D3 were done with one primer set that amplifies a segment of ORF 26
(18), and experiment D2 was done with another that amplifies a segment of ORF
26 (5). The nested PCR products from experiment D1 were hybridized with a
previously described internal probe (18); all specimens positive by ethidium
bromide staining were also hybridization positive. The sensitivity of the nested
PCR was between 1 and 10 molecules for experiments D1 and D3. Experiment
D2 was of approximately 10-fold-lower sensitivity, and extra bands appeared
during the nested PCR. These extra bands were not normally observed with these
primers and were traced to a specific lot of Taq DNA polymerase. Several
precautions were taken to avoid PCR contamination; extraction of DNA and
PCRs were done in separate rooms with dedicated equipment that was extensively washed after each experiment.
(v) Laboratory E. Specimen processing, PCR primers that amplify a segment
of ORF 26, and amplification conditions were described previously (11) (experiment E). DNA was eluted in 20 ml of water, and 200 ng or 4 ml was used in each
PCR. The negative result for the 10-copy BCBL-1 specimen may have been due
to an error either in aliquoting the cells or during DNA preparation, because the
specimen was also negative for erv-3, a diploid endogenous virus. PCR for erv-2
was positive in unnested reactions for all but one semen specimen.

RESULTS
Blinded, otherwise identical panels consisting of semen
specimens and both positive and negative controls were analyzed by solution-based PCR in five laboratories, including
laboratories that have described results representing both ends
of the prevalence spectrum in previous work. Both nested and
nonnested PCR assays were used. In some laboratories, the
materials were assayed more than once, with the same or
different primers. For analysis and discussion, each attempt
was treated as a separate experiment.
Controls. The results from the blinded control materials are
summarized in Table 1. In all experiments, the positive controls were identified as positive down to the level of 100 copies
per 10 ml of template. False-positive results for the negative
controls occurred in experiments A1, B2, D1, and D3. The only
positive results obtained from the positive control with 1 copy
per 10 ml occurred in experiments with false-positive results for
the negative controls (experiments B2, D1, and D3), raising the
possibility that the apparent high sensitivity was due to PCR
contamination. Positive results for negative controls occurred
only in experiments that employed nested PCR.
Semen. As indicated by false positives for the negative controls, experiments A1, B2, D1, and D3 were affected by PCR
contamination. Experiment B1 must be considered to be possibly contaminated because (i) it identified the highest percentage of semen specimens as being positive in spite of being
sensitive only down to the level of 100 copies per 10 ml and (ii)
three of the seven negative controls were positive in the sub-
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sequent nested PCR assay (experiment B2). Thus, of the 10
solution PCR experiments, at least half (A1, B1, B2, D1, and
D3) had results consistent with at least a low level of PCR
contamination. In the experiments with no evidence for contamination (A2, C1, C2, D2, and E), three (8%) of the semen
specimens were positive; none of the three was positive in
more than one experiment. Overall, the 37 semen specimens
were positive in 3 (1.6%) of 184 PCRs done in experiments
with no evidence for contamination. Of note is that two of the
three positive semen specimens were obtained from healthy
donors.
Experiment C1 included a semiquantitative component. The
observed values of 500, 20, and 10 copies for what turned out
to be the positive controls corresponded well with their calculated values of 1,000, 100, and 10, respectively.
In addition to the solution PCR experiments described
above, the blinded panel was also analyzed by in situ PCR, with
many specimens testing positive. However, the positive and
negative control cells were destroyed by the freeze-thaw cycle
and could not be analyzed, precluding meaningful interpretation of the experiment. It will be important to study the sensitivity and specificity of in situ PCR in an experiment designed
for that purpose.
DISCUSSION
It is important to understand the prevalence and routes of
transmission of HHV-8. If the virus primarily infects people
who have or are likely to develop KS (high infection-to-disease
ratio), strategies for interrupting its transmission would differ
from those for a situation in which the virus is widespread in
the population and the associated disease is rare. Hypotheses
regarding HHV-8 mechanisms of persistence and pathogenesis
differ markedly between the extremes of high (low prevalence)
and low (high prevalence) infection-to-disease ratios.
This work was intended to answer one of the questions that
have emerged because of the widely varying values that have
been reported for the prevalence of HHV-8 DNA in semen,
specifically, whether similar results would be obtained in different laboratories from the same experimental materials. The
answer is that in experiments with no evidence for contamination, absolute sensitivities were similar and agreement on semen specimens was high, with only sporadic semen specimens
being identified as positive. Several other observations can be
made based on these results.
(i) PCR contamination appears to have occurred in three of
the five laboratories, as evidenced by positive reactions in presumed negative controls. Contamination was evident only in
experiments that included a nested PCR step. While it is impossible to state with absolute certainty that the controls were
truly negative, these materials were prepared before aliquoting
of the semen specimens and the preparation was done in a cell
culture room that had not been used for any HHV-8 work.
Although the positive controls were shipped in the same container as the other specimens, contamination during shipping
seems unlikely. If such contamination had occurred, many
more samples beyond the negative controls would have been
contaminated. PCR contamination may have occurred during
specimen extraction and manipulation because of equipment
contamination that may have been associated with the high
DNA load in some of the positive controls included with the
test panel. For laboratory D, no contamination of extraction
control specimens consisting of buffer and salmon sperm DNA
was detected in other work. In those studies, positive control
specimens, KS lesions, and any other samples except semen
from HIV-negative donors were processed in dedicated rooms
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with dedicated equipment (17, 18). Nonetheless, because KS
lesions possibly harbor HHV-8 at copy numbers higher than
those included in the positive controls, and because it is difficult to preidentify all high-copy-number specimens, laboratory
methods need to be sufficiently rigorous for this level of DNA
load not to be a source of contamination.
Although it is impossible to extrapolate unequivocally from
these results to previously published results, it is worth noting
that two of the laboratories that identified negative controls as
positive previously reported high prevalences of HHV-8 in
semen; those that reported all negative controls as negative
have reported low HHV-8 DNA prevalence in semen. Geographic or population-based differences in HHV-8 presence in
semen remain possible explanations for the previously published observations from Italy (17). In further studies, both
DNA samples and aliquots of unprocessed semen from Italy
were found to be HHV-8 DNA positive in a blinded analysis
performed in the United Kingdom (19).
(ii) Several independent observations suggest that a previously unrecognized variable in analyses of semen specimens
from AIDS patients is oligospermia, or reduced sperm production, which is sometimes observed in HIV-infected men (21).
Consistent with this hypothesis, one laboratory found that no
sperm were visible by light microscopy in two of the seven
specimens from HIV-positive men, and two laboratories noted
that one of these specimens was clear, rather than having the
customary milky appearance of semen; very small cell pellets
were visible after centrifugation. Subsequent studies should
control for volume, semen cell count, and sperm concentration.
(iii) DNA extracted from approximately 7.5 ml of neat semen
was analyzed in each solution PCR. Thus, DNA extracted from
an equivalent of about 37.5 ml of neat semen from lysates that
represented a total neat semen volume of 262.5 ml from each
specimen was analyzed in the five runs for which there was no
evidence for contamination. The results can be interpreted to
indicate that HHV-8 DNA is occasionally present in the semen
of both healthy donors and HIV-infected men (7 and 14% of
ejaculates, respectively) but at concentrations that preclude its
frequent or reliable detection by PCR (1.3 and 6% of the
corresponding reactions were positive, respectively). However,
given that no specimen was positive in more than one assay and
that the positive assays were not confirmed with a different
primer set or by sequence analysis, we cannot exclude the
possibility that the positive results in the “clean” experiments
resulted from low-level contamination.
(iv) An additional variable that should be considered in
subsequent studies of semen specimens obtained from artificial-insemination banks is the possibility that the human serum
albumin used in the semen stabilization buffer is contaminated
(perhaps intermittently and at a low concentration) with
HHV-8 DNA present in the pooled serum from which albumin
is prepared. Although this may seem unlikely, the frequent
detection of HHV-8 DNA in the blood of KS and AIDS patients, plus the recent description of a blood donor from whose
blood HHV-8 could be repeatedly cultured (3), lends credence
to this hypothesis and suggests that albumin used to prepare
semen stabilization buffers should be tested for the presence of
HHV-8 DNA.
This study offers several lessons. It is clear that PCR contamination of semen samples can and does occur. This contamination appears to be related to the low copy numbers of
HHV-8 DNA in semen and the use of nested PCR methods for
their amplification. Experimental designs need to include sufficient negative controls to allow discrimination of true-positive results from intermittent false-positive results. We recom-
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mend the following: (i) confirmation of positive PCR results by
amplification of at least a second genetic locus and by performing nucleotide sequence heterogeneity analyses to demonstrate
that experimental amplimers are derived from independent
sources, (ii) not processing materials with known or presumed
high viral DNA loads together with specimens with low viral
DNA loads, and (iii) assessment of incorporation of biochemical methods for amplimer inactivation, such as uracil incorporation or digestion, into PCR procedures. In situ PCR methods need to be tested in blinded comparisons similar to those
done in this study. This study emphasizes the importance of
performing blinded, multi-institution experiments to provide a
coherent basis for comparing results and to motivate standardization of methods.
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